Tag: Epzicom

According to the NIH, nucleoside reverse transcriptase inhibitors (NRTIs) are the backbone of many combination antiretroviral therapies for HIV. This class is precisely **what class of drugs do abacavir and lamivudine belong to**, forming a critical part of modern HIV management.

In late 2023 and early 2024, manufacturer ViiV Healthcare phased out several brand-name formulations containing abacavir, including Ziagen tablets. This has led to widespread confusion and questions about the medication's status, but is abacavir discontinued? The answer is more complex, as generic versions and other formulations remain available for treating HIV.

In late 2023 and early 2024, the manufacturer of brand-name abacavir products, ViiV Healthcare, ceased distribution of several tablet formulations, including Ziagen, Epzicom, and Trizivir. This has led to widespread confusion and concerns about the drug's future, with many asking: is abacavir being discontinued entirely?